[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: CRISPR-Cas9 Gene Editing Technologies Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          By Application Overview

4.1       Introduction

4.1.1    Market Size & Forecast (Value)

4.2       Genome Engineering

4.2.1    Market Size & Forecast (Value)

4.3       Disease Models

4.3.1    Market Size & Forecast (Value)

5          By End-User Overview

5.1       Introduction

5.1.1    Market Size & Forecast (Value)

5.2       Biotechnology & Pharmaceutical Companies

5.2.1    Market Size & Forecast (Value)

5.3       Academic & Government Research Institutes

5.3.1    Market Size & Forecast (Value)

6          Regional Overview

6.1       Introduction

6.1.1    Market Size & Forecast (Value)

6.2       America

6.2.1    North America

6.2.1.1 U.S.

6.2.1.1.1          By Application

6.2.1.1.2          By End-User

6.2.1.2 Canada

6.2.1.2.1          By Application

6.2.1.2.2          By End-User

6.2.1.3 Mexico

6.2.1.3.1          By Application

6.2.1.3.2          By End-User

6.2.1.4 Latin America

6.2.1.4.1          By Application

6.2.1.4.2          By End-User

6.3       Europe

6.3.1    Market Size & Forecast (Value)

6.3.2    Germany

6.3.2.1 By Application

6.3.2.2 By End-User

6.3.3    France

6.3.3.1 By Application

6.3.3.2 By End-User

6.3.4    U.K.

6.3.4.1 By Application

6.3.4.2 By End-User

6.3.5    Italy

6.3.5.1 By Application

6.3.5.2 By End-User

6.3.6    Spain

6.3.6.1 By Application

6.3.6.2 By End-User

6.3.7    Rest of Europe

6.3.7.1 By Application

6.3.7.2 By End-User

6.4       Asia Pacific

6.4.1    Market Size & Forecast (Value)

6.4.2    Japan

6.4.2.1 By Application

6.4.2.2 By End-User

6.4.3    China

6.4.3.1 By Application

6.4.3.2 By End-User

6.4.4    Australia

6.4.4.1 By Application

6.4.4.2 By End-User

6.4.5    India

6.4.5.1 By Application

6.4.5.2 By End-User

6.4.6    South Korea

6.4.6.1 By Application

6.4.6.2 By End-User

6.4.7    Rest of Asia-Pacific

6.4.7.1 By Application

6.4.7.2 By End-User

6.5       Middle East & Africa

6.5.1    Market Size & Forecast (Value)

6.5.2    Saudi Arabia

6.5.2.1 By Application

6.5.2.2 By End-User

6.5.3    South Africa

6.5.3.1 By Application

6.5.3.2 By End-User

6.5.4    Kuwait

6.5.4.1 By Application

6.5.4.2 By End-User

6.5.5    Rest of Middle East & Africa

6.5.5.1 By Application

6.5.5.2 By End-User

7          Company Profile

7.1       Thermo Fisher Scientific (U.S.)

7.1.1    Company Overview

7.1.2    Financial Performance

7.1.3    Recent Developments

7.1.4    Product Portfolio

7.2       Merck & Co., Inc. (U.S.)

7.2.1    Company Overview

7.2.2    Financial Performance

7.2.3    Recent Developments

7.2.4    Product Portfolio

7.3       Genscript (U.S.)

7.3.1    Company Overview

7.3.2    Financial Performance

7.3.3    Recent Developments

7.3.4    Product Portfolio

7.4       Sangamo Therapeutics, Inc. (U.S.)

7.4.1    Company Overview

7.4.2    Financial Performance

7.4.3    Recent Developments

7.4.4    Product Portfolio

7.5       Integrated DNA Technologies, Inc. (U.S.)

7.5.1    Company Overview

7.5.2    Financial Performance

7.5.3    Recent Developments

7.5.4    Product Portfolio

7.6       Lonza (Switzerland)

7.6.1    Company Overview

7.6.2    Financial Performance

7.6.3    Recent Developments

7.6.4    Product Portfolio

7.7       New England Biolabs (U.S.)

7.7.1    Company Overview

7.7.2    Financial Performance

7.7.3    Recent Developments

7.7.4    Product Portfolio

7.8       CRISPR THERAPEUTICS (Switzerland)

7.8.1    Company Overview

7.8.2    Financial Performance

7.8.3    Recent Developments

7.8.4    Product Portfolio

            7.9       Mirus Bio LLC (U.S.)

7.9.1    Company Overview

7.9.2    Financial Performance

7.9.3    Recent Developments

7.9.4    Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports